Anti-inflammatory treatment also gives MACE reduction in high-risk patients with kidney disease
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Predicting 30-year CV outcomes in women
Paul Ridker, MD
Peter Libby, MD
Rein Oostveen, MD
Lukas Hoes, MD
David Conen, MD